TAILOR-PCI and the Role of Genotype-Guided Antiplatelet Therapy TAILOR-PCI and the Role of Genotype-Guided Antiplatelet Therapy

Investigators from the TAILOR PCI trial that used point-of-care genomic testing to identify clopidogrel nonresponders discuss the take-homes and why genotyping may be better than platelet function tests.Mayo Clinic
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Commentary Source Type: news